Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Endo Int'l Plc (ENDP)

Endo Int'l Plc (ENDP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Endo Launches Generic Version of Afinitor® (everolimus) Tablets in the United States

Endo International plc (NASDAQ: ENDP) today announced that one of its operating companies, Par Pharmaceutical (Par), has received approval for and launched generic Afinitor® (everolimus) 2.5 mg, 5 mg...

ENDP : 4.57 (-0.44%)
Why Is Endo (ENDP) Up 12.3% Since Last Earnings Report?

Endo (ENDP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ENDP : 4.57 (-0.44%)
Options Traders Expect Huge Moves in Endo (ENDP) Stock

Investors need to pay close attention to Endo (ENDP) stock based on the movements in the options market lately.

ENDP : 4.57 (-0.44%)
J&J's (JNJ) New Tests Reveal No Asbestos in Baby Powders

J&J (JNJ) says that two third-party labs conducted 155 tests on samples of its baby powders. All these tests confirm that the talc does not contain asbestos, a known carcinogen.

JNJ : 140.48 (-0.01%)
ENDP : 4.57 (-0.44%)
TEVA : 9.64 (-1.83%)
MNK : 3.37 (+2.74%)
BioDelivery's Belbuca Sales & Symproic Addition Encouraging

BioDelivery's (BDSI) efforts to increase preferred coverage for Belbuca and the acquisition of the rights to Symproic are likely to help continue its momentum.

CI : 190.76 (-2.65%)
BDSI : 6.41 (+0.31%)
ALKS : 21.71 (-0.14%)
ENDP : 4.57 (-0.44%)
Fed Reportedly Opens Criminal Investigation on Opioid Makers

Shares of some manufacturers and distributors of opioid drugs decline on Tuesday following reports that a criminal probe has been initiated by federal prosecutors.

JNJ : 140.48 (-0.01%)
ENDP : 4.57 (-0.44%)
MNK : 3.37 (+2.74%)
TEVA : 9.64 (-1.83%)
MCK : 142.19 (-0.48%)
ABC : 85.95 (-0.51%)
AMRX : 3.55 (-0.28%)
Specialty Generic Drugs Market 2018-2025|Market Size, Market Status, Top key players, and Forecasts

The global Specialty Generic Drugs Market is anticipated to reach USD 190.9 billion by 2025 according to a new study published by Polaris Market Research. Specialty Generics drugs are the generic forms...

ENDP : 4.57 (-0.44%)
NVS : 92.51 (-0.02%)
PFE : 38.23 (-0.23%)
VRX.TO : 30.80 (-3.33%)
Endo to Participate at Bank of America Merrill Lynch Leveraged Finance Conference

Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the Bank of America Merrill Lynch Leveraged Finance Conference in Boca Raton, Florida...

ENDP : 4.57 (-0.44%)
Endo's (ENDP) BLA for Cellulite Treatment Accepted by FDA

The FDA accepts Endo's (ENDP) BLA for CCH for the treatment of cellulite in the buttocks.

ENDP : 4.57 (-0.44%)
JAZZ : 150.57 (-0.51%)
MNK : 3.37 (+2.74%)
TEVA : 9.64 (-1.83%)
Company News For Nov 21, 2019

Companies in the news are: URBN, KNSA, ACB, ENDP

ENDP : 4.57 (-0.44%)
URBN : 26.99 (+1.05%)
KNSA : 13.42 (+18.03%)
ACB : 2.55 (-2.67%)
Why the Global Pain Management Drug Market is Adopting More Non-Opioid Options

It appears that the reign of the opioid drugs in the global pain management markets could be coming to an end. While opioids have long been the 'best' choice to address the pain patients suffer from various...

QBIO : 1.3500 (+0.75%)
MYOV : 15.92 (-0.56%)
HRTX : 25.78 (+0.62%)
BCRX : 2.74 (+4.98%)
ENDP : 4.57 (-0.44%)
Endo Announces FDA's Acceptance of Original Biologics License Application (BLA) for Collagenase Clostridium Histolyticum (CCH) in Patients with Cellulite

Endo International plc (NASDAQ: ENDP) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the original Biologics License Application (BLA) for collagenase clostridium...

ENDP : 4.57 (-0.44%)
BioDelivery (BDSI) Stock Up on Q3 Earnings Beat & Raised View

BioDelivery (BDSI) beats earnings and sales expectations in the third quarter of 2019. The company raises its 2019 revenue guidance.

BDSI : 6.41 (+0.31%)
ANIK : 55.48 (-0.11%)
ALKS : 21.71 (-0.14%)
ENDP : 4.57 (-0.44%)
Post-operative Pain Management Market 2019- Statistics Share, Growth, Industry Size, Future Trends, Segmentation, Gross Margin, Opportunities, Demand, Global Forecast to 2023

BAX : 82.01 (+0.56%)
LLY : 120.46 (+0.18%)
ENDP : 4.57 (-0.44%)
GSK : 46.03 (+0.88%)
TEVA : 9.64 (-1.83%)
VRX.TO : 30.80 (-3.33%)
Endo (ENDP) Q3 Earnings & Revenues Beat Estimates, Down Y/Y

Endo (ENDP) reports better-than-expected results for the third quarter as Xiaflex delivers a strong performance.

LCI : 8.98 (-2.18%)
FGEN : 48.60 (+1.76%)
ENDP : 4.57 (-0.44%)
PTLA : 27.81 (-1.56%)
Endo International Plc to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / November 5, 2019 / Endo International Plc (NASDAQ: ) will be discussing their earnings results in their 2019 Third Quarter Earnings to be held on November 5, 2019 at 7:30 AM...

ENDP : 4.57 (-0.44%)
Endo International (ENDP) Q3 Earnings and Revenues Top Estimates

Endo (ENDP) delivered earnings and revenue surprises of 13.21% and 3.09%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

ENDP : 4.57 (-0.44%)
Endo Reports Third-Quarter 2019 Financial Results

- Operating Performance Led by Year-over-Year Double-Digit-Percentage Revenue Growth in Sterile Injectables and in Specialty Products Portfolio of Branded Pharmaceuticals -

ENDP : 4.57 (-0.44%)
Endo Implements CEO Succession Plan

Paul Campanelli Appointed Chairman of the Board, Will Also Continue as President and Chief Executive Officer Until Successor Appointed; Roger Kimmel Appointed Senior Independent Director

ENDP : 4.57 (-0.44%)
Earnings Preview: Endo International (ENDP) Q3 Earnings Expected to Decline

Endo (ENDP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ENDP : 4.57 (-0.44%)

Van Meerten Stock Picks

The 5 Best Large Caps
I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.
CCI -2.74 , AIZ -0.70 , SBAC -3.78 , SO -0.77 , WELL -0.79
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar